Showing results (341-350 of 392) with videos related to
Sort By:
Pageof 40
Bioorganic Chemistry|June 13, 2016
Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybridsZahra Najafi, Mina Saeedi, Mohammad Mahdavi, et al.Chemistry & Biodiversity|December 20, 2022
Ugi Bis-Amide Derivatives as Tyrosinase Inhibitor; Synthesis, Biology Assessment, and in Silico AnalysisFaeze Yousefnejad, Aida Iraji, Reyhaneh Sabourian, et al.Molecular Diversity|March 20, 2020
Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studiesMohammad Sadegh Asgari, Maryam Mohammadi-Khanaposhtani, Zeinab Sharafi, et al.RSC Advances|August 27, 2025
New 1E,1'E-hydrazine-bis(phenoxy-1,2,3-triazol-acetamide) derivatives as potent inhibitors against acetylcholinesterase, butyrylcholinesterase, and α-glucosidaseShahab Kermaninia, Maryam Mohammadi-Khanaposhtani, Halil Şenol, et al.Future Medicinal Chemistry|May 10, 2017
Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chainFarzad Mehrabi, Yaghoub Pourshojaei, Alireza Moradi, et al.Scientific Reports|July 31, 2023
Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidaseFaeze Yousefnejad, Mahyar Mohammadi-Moghadam-Goozali, Mohammad Hosein Sayahi, et al.Scientific Reports|January 2, 2023
New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulationNavid Dastyafteh, Milad Noori, Mohammad Nazari Montazer, et al.Bioorganic Chemistry|February 5, 2022
Synthesis and in vitro urease inhibitory activity of 5-nitrofuran-2-yl-thiadiazole linked to different cyclohexyl-2-(phenylamino)acetamides, in silico and kinetic studiesMehdi Asadi, Aida Iraji, Maede Sherafati, et al.RSC Advances|April 15, 2022
Magnetic graphene oxide-lignin nanobiocomposite: a novel, eco-friendly and stable nanostructure suitable for hyperthermia in cancer therapyReza Eivazzadeh-Keihan, Somayeh Asgharnasl, Hooman Aghamirza Moghim Aliabadi, et al.Archiv Der Pharmazie|September 1, 2021
Design, synthesis, and α-glucosidase-inhibitory activity of phenoxy-biscoumarin-N-phenylacetamide hybridsSamira Ansari, Homa Azizian, Keyvan Pedrood, et al.Pageof 40